Learn More About Our Innovative Biotechnology
Press Releases, Publications, & Videos

Press Releases
AVM Biotechnology Founder and CSO to Present Company Information and Clinical Trial Progress at Life Science Innovation Northwest

Press Releases
AVM Awarded $1.6 Million Phase II SBIR Grant to Study AVM0703’s Potential to Reverse Type 1 Diabetes

Press Releases
C-Suite Expands in Anticipation of Commercialization

Publications
AVM0703 Tumor Debulking Enhances Cy/Flu Efficacy

Publications
Very-High Dose Dexamethasone Mobilizes Endogenous Bi-Specific Gamma Delta+ NKT Cells

Press Releases
FDA Approves Accelerated Dosing in NHL/Leukemia Clinical Trial

Press Releases
Full Enrollment of First Cohort of Relapsed/Refractory Non-Hodgkin’s Lymphoma Patients dosed with AVM0703

Videos
Theresa Deisher Speaks at ESWI Influenza Conference

Publications
Pharma’s Almanac Features AVM0703

Press Releases
AVM Biotechnology CEO/CSO Selected to Speak at ESWI Conference in Novel and Outstanding Discoveries Track

Videos
What is AVM0703? Find Out!

Press Releases
President Receives Dexamethasone Treatment

Press Releases
AVM Receives FDA Permission for Clinical Trials in COVID-19/ARDS

Press Releases
AVM Expands Executive Team, Appoints Janet R. Rea COO

Videos
Amplifying Scientific Innovation Podcast

Press Releases
AVM’s Dexamethasone Formulation Has Potential For Greater Impact Than Oxford’s

Videos
Oxford/AVM’s potential COVID-19 Treatment Featured on KOMO News

Press Releases
AVM Awarded SBIR Grant From National Cancer Institute

Press Releases
FDA Approves AVM0703 Clinical Trials in R/R Non-Hodgkins Lymphoma

Videos
Cavendish Global 2020
